FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3204060182> ?p ?o ?g. }

• W3204060182 endingPage "2248" @default.
• W3204060182 startingPage "2239" @default.
• W3204060182 abstract "Relapse and treatment adherence to paliperidone palmitate once-monthly (PP1M) and three-monthly (PP3M) formulations in patients with schizophrenia were evaluated and compared using health claims data.Data (June 2015─June 2018) obtained from the MarketScan® Multi-State Medicaid Database were retrospectively analyzed. Patients aged ≥18 years with ≥1 claim for schizophrenia diagnosis prior to and/or at index date (i.e., date of first PP3M prescription record for PP3M patients and same month/year as the matched PP3M patients for PP1M patients) and continuous enrollment in the insurance plan for ≥12 months prior to index date (baseline) were included. PP1M cohort included patients who received ≥4 PP1M doses. PP3M patients were matched with PP1M patients (1:3) using propensity score matching and prevalent new user design. Outcome measures were relapse rate, time to relapse, proportion of days covered (PDC), and level of treatment adherence defined by PDC in five levels. Time to relapse was compared by Kaplan-Meier survival curves and log-rank test with the hazard ratio calculated using Cox proportion hazards model; PDC by t-test, and relapse rate and PDC categories by chi-square test.A total of 1564 patients (428 PP3M and 1136 PP1M) were included. Relapse rate was lower in PP3M cohort (10.5%) compared with PP1M cohort (15.7%). Incidence rate of relapse was 8.98/100 person-years (PY) in PP3M cohort and 13.81/100 PY in PP1M cohort. After a mean (SD) follow-up of 456.1 (240.28) days in PP3M cohort and 465.4 (237.95) days in PP1M cohort, PP3M patients had a significantly lower relapse risk (hazard ratio: 0.65, 95% CI: 0.47, 0.90) than PP1M patients. Treatment adherence was significantly (p<0.0001) higher in PP3M versus PP1M cohort.Risk of relapse was significantly lower, and treatment adherence was significantly higher in PP3M cohort compared with PP1M cohort. Higher treatment adherence was associated with lower relapse rate." @default.
• W3204060182 created "2021-10-11" @default.
• W3204060182 creator A5011875552 @default.
• W3204060182 creator A5015471100 @default.
• W3204060182 creator A5054298186 @default.
• W3204060182 creator A5068346988 @default.
• W3204060182 creator A5076376973 @default.
• W3204060182 creator A5081125396 @default.
• W3204060182 creator A5082147342 @default.
• W3204060182 creator A5084952345 @default.
• W3204060182 creator A5086849309 @default.
• W3204060182 creator A5088148471 @default.
• W3204060182 creator A5091786784 @default.
• W3204060182 date "2021-10-01" @default.
• W3204060182 modified "2023-10-03" @default.
• W3204060182 title "Relapse and Treatment Adherence in Patients with Schizophrenia Switching from Paliperidone Palmitate Once-Monthly to Three-Monthly Formulation: A Retrospective Health Claims Database Analysis" @default.
• W3204060182 cites W1151536748 @default.
• W3204060182 cites W1953157543 @default.
• W3204060182 cites W1997763686 @default.
• W3204060182 cites W2013280864 @default.
• W3204060182 cites W2022692147 @default.
• W3204060182 cites W2057464084 @default.
• W3204060182 cites W2065542563 @default.
• W3204060182 cites W2068596607 @default.
• W3204060182 cites W2075029547 @default.
• W3204060182 cites W2088866491 @default.
• W3204060182 cites W2103690351 @default.
• W3204060182 cites W2104175708 @default.
• W3204060182 cites W2117484440 @default.
• W3204060182 cites W2124873726 @default.
• W3204060182 cites W2138418531 @default.
• W3204060182 cites W2143855802 @default.
• W3204060182 cites W2151641071 @default.
• W3204060182 cites W2160096204 @default.
• W3204060182 cites W2162959382 @default.
• W3204060182 cites W2165647449 @default.
• W3204060182 cites W2167532647 @default.
• W3204060182 cites W2290987402 @default.
• W3204060182 cites W2326858746 @default.
• W3204060182 cites W2517639623 @default.
• W3204060182 cites W2736421813 @default.
• W3204060182 cites W2740548674 @default.
• W3204060182 cites W2778613387 @default.
• W3204060182 cites W2781627951 @default.
• W3204060182 cites W2790133017 @default.
• W3204060182 cites W2795999196 @default.
• W3204060182 cites W2887988025 @default.
• W3204060182 cites W2888733935 @default.
• W3204060182 cites W2901006613 @default.
• W3204060182 cites W2904839581 @default.
• W3204060182 cites W2039812876 @default.
• W3204060182 doi "https://doi.org/10.2147/ppa.s322880" @default.
• W3204060182 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8495229" @default.
• W3204060182 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34629867" @default.
• W3204060182 hasPublicationYear "2021" @default.
• W3204060182 type Work @default.
• W3204060182 sameAs 3204060182 @default.
• W3204060182 citedByCount "12" @default.
• W3204060182 countsByYear W32040601822022 @default.
• W3204060182 countsByYear W32040601822023 @default.
• W3204060182 crossrefType "journal-article" @default.
• W3204060182 hasAuthorship W3204060182A5011875552 @default.
• W3204060182 hasAuthorship W3204060182A5015471100 @default.
• W3204060182 hasAuthorship W3204060182A5054298186 @default.
• W3204060182 hasAuthorship W3204060182A5068346988 @default.
• W3204060182 hasAuthorship W3204060182A5076376973 @default.
• W3204060182 hasAuthorship W3204060182A5081125396 @default.
• W3204060182 hasAuthorship W3204060182A5082147342 @default.
• W3204060182 hasAuthorship W3204060182A5084952345 @default.
• W3204060182 hasAuthorship W3204060182A5086849309 @default.
• W3204060182 hasAuthorship W3204060182A5088148471 @default.
• W3204060182 hasAuthorship W3204060182A5091786784 @default.
• W3204060182 hasBestOaLocation W32040601821 @default.
• W3204060182 hasConcept C118552586 @default.
• W3204060182 hasConcept C126322002 @default.
• W3204060182 hasConcept C167135981 @default.
• W3204060182 hasConcept C17923572 @default.
• W3204060182 hasConcept C207103383 @default.
• W3204060182 hasConcept C2776412080 @default.
• W3204060182 hasConcept C2777126507 @default.
• W3204060182 hasConcept C2780057945 @default.
• W3204060182 hasConcept C2908997079 @default.
• W3204060182 hasConcept C44249647 @default.
• W3204060182 hasConcept C50382708 @default.
• W3204060182 hasConcept C71924100 @default.
• W3204060182 hasConcept C72563966 @default.
• W3204060182 hasConceptScore W3204060182C118552586 @default.
• W3204060182 hasConceptScore W3204060182C126322002 @default.
• W3204060182 hasConceptScore W3204060182C167135981 @default.
• W3204060182 hasConceptScore W3204060182C17923572 @default.
• W3204060182 hasConceptScore W3204060182C207103383 @default.
• W3204060182 hasConceptScore W3204060182C2776412080 @default.
• W3204060182 hasConceptScore W3204060182C2777126507 @default.
• W3204060182 hasConceptScore W3204060182C2780057945 @default.
• W3204060182 hasConceptScore W3204060182C2908997079 @default.
• W3204060182 hasConceptScore W3204060182C44249647 @default.
• W3204060182 hasConceptScore W3204060182C50382708 @default.
• W3204060182 hasConceptScore W3204060182C71924100 @default.

• next